170 related articles for article (PubMed ID: 12356919)
1. Transcription factors RUNX1/AML1 and RUNX2/Cbfa1 dynamically associate with stationary subnuclear domains.
Harrington KS; Javed A; Drissi H; McNeil S; Lian JB; Stein JL; Van Wijnen AJ; Wang YL; Stein GS
J Cell Sci; 2002 Nov; 115(Pt 21):4167-76. PubMed ID: 12356919
[TBL] [Abstract][Full Text] [Related]
2. Subnuclear targeting of Runx/Cbfa/AML factors is essential for tissue-specific differentiation during embryonic development.
Choi JY; Pratap J; Javed A; Zaidi SK; Xing L; Balint E; Dalamangas S; Boyce B; van Wijnen AJ; Lian JB; Stein JL; Jones SN; Stein GS
Proc Natl Acad Sci U S A; 2001 Jul; 98(15):8650-5. PubMed ID: 11438701
[TBL] [Abstract][Full Text] [Related]
3. Regulatory controls for osteoblast growth and differentiation: role of Runx/Cbfa/AML factors.
Lian JB; Javed A; Zaidi SK; Lengner C; Montecino M; van Wijnen AJ; Stein JL; Stein GS
Crit Rev Eukaryot Gene Expr; 2004; 14(1-2):1-41. PubMed ID: 15104525
[TBL] [Abstract][Full Text] [Related]
4. Temporal and spatial parameters of skeletal gene expression: targeting RUNX factors and their coregulatory proteins to subnuclear domains.
Stein GS; Lian JB; Stein JL; van Wijnen AJ; Choi JY; Pratap J; Zaidi SK
Connect Tissue Res; 2003; 44 Suppl 1():149-53. PubMed ID: 12952189
[TBL] [Abstract][Full Text] [Related]
5. A specific targeting signal directs Runx2/Cbfa1 to subnuclear domains and contributes to transactivation of the osteocalcin gene.
Zaidi SK; Javed A; Choi JY; van Wijnen AJ; Stein JL; Lian JB; Stein GS
J Cell Sci; 2001 Sep; 114(Pt 17):3093-102. PubMed ID: 11590236
[TBL] [Abstract][Full Text] [Related]
6. Oncogenic potential of the RUNX gene family: 'overview'.
Ito Y
Oncogene; 2004 May; 23(24):4198-208. PubMed ID: 15156173
[TBL] [Abstract][Full Text] [Related]
7. Overlapping expression of Runx1(Cbfa2) and Runx2(Cbfa1) transcription factors supports cooperative induction of skeletal development.
Smith N; Dong Y; Lian JB; Pratap J; Kingsley PD; van Wijnen AJ; Stein JL; Schwarz EM; O'Keefe RJ; Stein GS; Drissi MH
J Cell Physiol; 2005 Apr; 203(1):133-43. PubMed ID: 15389629
[TBL] [Abstract][Full Text] [Related]
8. The transcriptionally active form of AML1 is required for hematopoietic rescue of the AML1-deficient embryonic para-aortic splanchnopleural (P-Sp) region.
Goyama S; Yamaguchi Y; Imai Y; Kawazu M; Nakagawa M; Asai T; Kumano K; Mitani K; Ogawa S; Chiba S; Kurokawa M; Hirai H
Blood; 2004 Dec; 104(12):3558-64. PubMed ID: 15271791
[TBL] [Abstract][Full Text] [Related]
9. Structural analyses of DNA recognition by the AML1/Runx-1 Runt domain and its allosteric control by CBFbeta.
Tahirov TH; Inoue-Bungo T; Morii H; Fujikawa A; Sasaki M; Kimura K; Shiina M; Sato K; Kumasaka T; Yamamoto M; Ishii S; Ogata K
Cell; 2001 Mar; 104(5):755-67. PubMed ID: 11257229
[TBL] [Abstract][Full Text] [Related]
10. The RUNX1 Runt domain at 1.25A resolution: a structural switch and specifically bound chloride ions modulate DNA binding.
Bäckström S; Wolf-Watz M; Grundström C; Härd T; Grundström T; Sauer UH
J Mol Biol; 2002 Sep; 322(2):259-72. PubMed ID: 12217689
[TBL] [Abstract][Full Text] [Related]
11. Impaired intranuclear trafficking of Runx2 (AML3/CBFA1) transcription factors in breast cancer cells inhibits osteolysis in vivo.
Javed A; Barnes GL; Pratap J; Antkowiak T; Gerstenfeld LC; van Wijnen AJ; Stein JL; Lian JB; Stein GS
Proc Natl Acad Sci U S A; 2005 Feb; 102(5):1454-9. PubMed ID: 15665096
[TBL] [Abstract][Full Text] [Related]
12. Upstream and downstream targets of RUNX proteins.
Otto F; Lübbert M; Stock M
J Cell Biochem; 2003 May; 89(1):9-18. PubMed ID: 12682904
[TBL] [Abstract][Full Text] [Related]
13. Point mutation in AML1 disrupts subnuclear targeting, prevents myeloid differentiation, and effects a transformation-like phenotype.
Vradii D; Zaidi SK; Lian JB; van Wijnen AJ; Stein JL; Stein GS
Proc Natl Acad Sci U S A; 2005 May; 102(20):7174-9. PubMed ID: 15870195
[TBL] [Abstract][Full Text] [Related]
14. Cbfbeta interacts with Runx2 and has a critical role in bone development.
Kundu M; Javed A; Jeon JP; Horner A; Shum L; Eckhaus M; Muenke M; Lian JB; Yang Y; Nuckolls GH; Stein GS; Liu PP
Nat Genet; 2002 Dec; 32(4):639-44. PubMed ID: 12434156
[TBL] [Abstract][Full Text] [Related]
15. Integration of Runx and Smad regulatory signals at transcriptionally active subnuclear sites.
Zaidi SK; Sullivan AJ; van Wijnen AJ; Stein JL; Stein GS; Lian JB
Proc Natl Acad Sci U S A; 2002 Jun; 99(12):8048-53. PubMed ID: 12060751
[TBL] [Abstract][Full Text] [Related]
16. Possible roles of Runx1 and Sox9 in incipient intramembranous ossification.
Yamashiro T; Wang XP; Li Z; Oya S; Aberg T; Fukunaga T; Kamioka H; Speck NA; Takano-Yamamoto T; Thesleff I
J Bone Miner Res; 2004 Oct; 19(10):1671-7. PubMed ID: 15355562
[TBL] [Abstract][Full Text] [Related]
17. Expression of Runx1, -2 and -3 during tooth, palate and craniofacial bone development.
Yamashiro T; Aberg T; Levanon D; Groner Y; Thesleff I
Gene Expr Patterns; 2002 Nov; 2(1-2):109-12. PubMed ID: 12617847
[TBL] [Abstract][Full Text] [Related]
18. Subnuclear targeting of Runx1 is required for synergistic activation of the myeloid specific M-CSF receptor promoter by PU.1.
Li X; Vradii D; Gutierrez S; Lian JB; van Wijnen AJ; Stein JL; Stein GS; Javed A
J Cell Biochem; 2005 Nov; 96(4):795-809. PubMed ID: 16149049
[TBL] [Abstract][Full Text] [Related]
19. Runx transcription factors and the developmental balance between cell proliferation and differentiation.
Coffman JA
Cell Biol Int; 2003; 27(4):315-24. PubMed ID: 12788047
[TBL] [Abstract][Full Text] [Related]
20. Multiple subnuclear targeting signals of the leukemia-related AML1/ETO and ETO repressor proteins.
Barseguian K; Lutterbach B; Hiebert SW; Nickerson J; Lian JB; Stein JL; van Wijnen AJ; Stein GS
Proc Natl Acad Sci U S A; 2002 Nov; 99(24):15434-9. PubMed ID: 12427969
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
